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Abstract 
This dissertation was written as part of the MSc in Management at the International 
Hellenic University.  
Demand for laboratory medical services is growing rapidly and is happening at a time of 
financial pressure, consequently, laboratory medicine specialists face the growing 
challenge of delivering a modern service of high quality. Better clinical laboratory tests, 
cancer screening tests, surgical pathology and cytopathology services, are especially 
important for cancer treatment, thus a Quality Management System (QMS) becomes a 
substantial component to guarantee constant improvement, quality assurance, 
repeatability, verification, and reproducibility, especially if we consider the fact that most 
of these tests involve several testing steps, that harbor the risk of multiple error mishaps. 
The objective of this study is to evaluate the impact of a QMS in a laboratory’s 
performance, by monitoring the change of pre-specified quality objectives before and 
after the implementation. A general description of ISO15189, a dedicated medical 
laboratory QMS, is preceded and definition of Quality and Quality Assurance is 
attempted. QMS evaluation method was based on the fulfillment of questionnaires by the 
employees, since all of them were engaged in the process, and no Laboratory Information 
System (LIS) was installed in the past, to access quantitative data. Preparation period, pre-
assessment results, main assessment results are described and explained. Moreover, the 
study captures employees’ experience and perspectives of the QMS implementation, 
comparing the results with literature findings. Interestingly the rate of most pre-analytical, 
analytical and post-analytical errors was significantly reduced after the QMS 
implementation, while at the same time personnel found it difficult to adjust to the new 
conditions, especially in the initial part of the process. Most of the findings seem to be 
consistent with those published in the literature. 
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1 Introduction 
1.1 Laboratory medical services 
Laboratory medicine is a medical specialty at the center of healthcare. When used 
optimally it generates knowledge that can facilitate patient safety, improve patient 
outcomes, shorten patient journeys and lead to more cost-effective healthcare (Graham H. 
Beastall, 2013). What is beyond doubt is that laboratory medicine is an essential element 
of the healthcare system providing users with pivotal information for the prevention, 
diagnosis, treatment and management of health and disease (Graham H. Beastall, 2013).1 
Diagnostics and clinical patient management have an interdependent relationship; 
laboratory data provide justification for clinical decision making, while clinical signs or 
the clinical management protocol often prompt laboratory testing (Trevor F. Peter, 2010). 
Demand for laboratory medicine services is growing rapidly and is happening at a time of 
financial pressure in healthcare across the developed world2. Consequently, laboratory 
medicine specialists face the growing challenge of delivering a modern service that is 
both clinically efficient and cost-effective. This can only be addressed by ‘working 
smarter’ – which includes eliminating waste, targeting clinical priorities, as well as 
adopting automation and communication technology (Graham H. Beastall, 2013). In other 
words, medical laboratory services need to be of high quality in order to support previous 
statement.  
Laboratory medicine is divided in two main sections, anatomic (or surgical) pathology 
and clinical pathology. The first one includes histopathology and cytopathology, while 
clinical microbiology, clinical chemistry, hematology and reproductive biology are 
included in the second section. Histopathology refers to the microscopic analysis of 
tissue, obtained through a biopsy and cytopathology is the microscopic examination of 
human body fluids. 
                                                 
1 http://www.ascls-sd.org/sitebuildercontent/sitebuilderfiles/laboratory_medicine_-
_a_national_status_reportmay08.pdf (Accessed November 2016). 
2 http://www.pathologists.org.uk/publications page/Carter%20 (Accessed September 2016) 
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1.2 Factors affecting the quality of laboratory medical services 
But what do we exactly mean when we refer to “high quality laboratory medical service”? 
As Fraser CG states, one simple definition is ‘the establishment of conditions such that 
the quality of all tests performed in laboratory medicine assists clinicians in practicing 
good medicine’ (Fraser CG, 2001). 
Figure 1 Graham H. Beastall. Adding value to laboratory medicine: a professional responsibility. Clin 
Chem Lab Med 2013; 51(1): 221–227 
 
In Figure 1, the components required to deliver a high-quality laboratory medicine service 
are summarized. On the left hand side of this figure are the factors required to assure the 
quality of an individual test result. On the right hand side are the parameters required by 
the laboratory to assure the quality of the supporting infrastructure in the present and into 
the future. Central to the quality service is that it meets the needs of users as assessed 
through surveys of user satisfaction. Figure 1 also reinforces that quality in laboratory 
medicine is the responsibility of everyone, not just of the laboratory director or quality 
manager.  
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1.3 QMS as an error avoidance measure by setting Quality 
Objectives 
The implementation of a laboratory quality management system (QMS) can significantly 
reduce both test reports variability and error frequency. Recently, emphasis is being 
shifted from infectious diseases, such as human immunodeficiency virus, tuberculosis, 
and malaria, to other non-communicable diseases such as cancer and cardiovascular 
diseases. Factors responsible for this shift are considered sustained economic growth, 
improvements in health care systems and delivery of services, increased population, and 
increased longevity (World Health Organization. 2008-2013). Additionally, the fact that 
scientific medical discoveries and advances on the study and analysis of the human 
genome have led to the establishment of personal health care models, explains the 
growing demand for improved laboratory and pathology diagnostic services (African 
Strategies for Advancing Pathology Group Members, 2015). Better clinical laboratory 
tests, cancer screening tests, surgical pathology and cytopathology services, are especially 
important for cancer treatment, thus a QMS becomes a substantial component to 
guarantee constant improvement, quality assurance, repeatability, verification, and 
reproducibility.  
Many tests, whether manual or automated, are subject to inaccuracy associated with lack 
of operator competence or failure to adhere to standard test procedures (Trevor F. Peter, 
2010). Tests performed manually are usually prone to inaccurate pipetting, cross-
contamination, or sample mix-up. Miscalibration errors, instrument defaults or 
malfunctions are common causes of inaccurate automated assays. Moreover, storage and 
expiration dates of reagents are critical factors that influence test results accuracy. Errors 
introduced during sample collection, labeling, transportation, registration at the laboratory 
and accessioning, or during the transcription and delivery of results, potentially lead to 
incorrect diagnosis and inappropriate treatment (Trevor F. Peter, 2010). It is noteworthy 
that pathology is a complex process that involves the following steps ( 
Figure 2):   
Pre-analytic phase: Correct specimen identification, adequacy of clinical history, safe 
specimen delivery, and accessioning errors are the main monitors in the pre-analytic 
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phase. Most of the elements of the pre-analytic phase aim at improving the accuracy of 
diagnosis, particularly adequate clinical history, since it has been shown to affect the 
accuracy and completeness of pathology reports (Nakleh RE et al, 2011). 
• Collection of specimen 
•  Identification of sample with patient’s ID (labeling) 
•  Transport of specimen 
Analytical phase: The analytic phase is divided into the technical part and medical part, 
and begins with gross examination of the specimen and ends with archiving of the final 
report. This is a multistep process that involves specimen handling by the pathologist, 
tissue embedding, sectioning, slide staining, possible use of special technics and 
microscopic slide interpretation. The accuracy of the final diagnosis is a measure of the 
effectiveness of these sequential steps (Nakleh RE, 2006). Block labelling errors, slide 
labelling errors, frequency of equipment defects, as well as external and internal 
validation of selected tests are important objectives for quality and improvement. 
 Technical analysis 
 Accession of the specimen into the laboratory and assignment of a unique protocol 
alphanumeric accession number 
 Submission of tissue cassettes into specific tissue processors, for the formation of 
paraffin blocks (formalin fixed paraffin embedded tissues – FFPE)  
 Subsequent placement of the FFPE blocks onto the microtome for tissue sections 
production 
 Adherence of tissue sections to labeled glass slides,  
 Staining of slides 
 Medical Analysis 
 Gross (macroscopic) examination of the specimen and selective submission of 
tissue samples into labeled tissue cassettes 
 Microscopic examination of glass slides by a pathologist 
Post-analytical phase: After deciding on the final diagnosis, the pathologist dictates the 
report, secretariat personnel transcripts the report, both the doctor and secretariat scan it 
for any corrections needed, and after verification, the report is delivered to the patient 
and/or clinician. The final step is archiving. Thus, quality indicators for this phase are 
transcription errors, verification errors, report delivery errors and incomplete reports. 
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Communication of critical values to the clinician is considered a crucial step in the whole 
process. 
 Dictation of report 
 Transcription of report 
 Correction 
 Verification 
 Report Delivery 
 Archiving of reports 
 
Figure 2 main steps from specimen ablation to report formation 
 
Additional, to the above quality improvement monitors are turnaround time (TAT) and 
customer satisfaction. While TAT may be fragmented into smaller components, the total 
TAT is the only measure by which the clinician or customer will judge the laboratory 
(Zarbo RJ et al, 2009).  Customer or clinician satisfaction is probably one of the most 
important measures of quality because it lends insight into the clinician’s perception of 
the laboratory, considering also clinician’s expectations (Nakleh RE et al, 2006).  Table 1 
and Table 2 summarize the main quality objectives in the three test phases. 
Total Testing Phases for Medical Labs
• Ordering rules
• Patient ID
• Collection
• Transport
• Acceptance criteria
pre-
analytic
• Technical analysis
• Medical analysisanalytic
• Report 
interpretation
• Report creation
• Report transport
• Data capture
post-
analytic
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Table 1 Quality objectives in each of the three test phases 
 
Table 2 TAT and Customer satisfaction components 
 
Pre-analytic
• specimen delivery
• specimen 
identification
• adequacy of clinical 
history
• accessioning errors
Analytic
• block labeling 
errors
• slide labeling errors
• frequency of 
equipment defects
• external & internal 
quality control
Post-analytic
• transcription errors
• verification errors
• report delivery 
errors
• incomplete reports
• communication of 
critical test results
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1.4 Research Objective 
The objective of this case study is to evaluate the laboratory performance of 
Microdiagnostics Ltd, a private surgical pathology and cytopathology laboratory in 
Northern Greece. Key quality objectives are specified to compare the performance before 
and after the implementation and maintenance of ISO 15189 standards, the latest standard 
for medical laboratory quality, as it will be further discussed in more detail. To 
successfully accomplish this, the methodology involved the initial development of a 
process mapping of the laboratory procedures. The impact of the QMS in TAT, and its 
influence in customer satisfaction was estimated by filling corresponding questionnaires. 
Furthermore, the study focused on capturing how the overall experience of the QMS 
implementation was perceived by the employees, again with the use of questionnaires. A 
detailed cost analysis is given, for a better understanding of the financial aspect of the 
QMS implementation. 
1.5 Structure of this document 
Chapter 2 starts by defining the terms Quality Control (QC) and Quality Assurance) and 
then is proceeds by analyzing what the ISO15189 is all about and what are the main best 
practices based on the literature. Chapter 3 presents the most frequent causes of errors in 
the routine work, and some proposed strategies to avoid them. In the first part of Chapter 
4 a review of the literature with respect to QMS implementation across the world in 
medical laboratories is attempted, ending up in describing the Greek reality. The second 
part depicts the advantages and disadvantages of ISO15189 implementation, based on the 
records of several laboratories across the globe. Chapter 5 is dedicated to the description 
of the private laboratory, highlighting its services and process flow in an effort to present 
and link its operational characteristics to any QC capacity, before QMS implementation. 
The methodology used for evaluating the QMS implementation in Microdiagnostics Ltd is 
described in chapter 6. 
Preparation procedures, pre-assessment and on site qualitative evaluation, by the Hellenic 
Accreditation System (ESYD) and the overall progress of ISO15189 implementation, are 
described in chapter 7. Chapter 8 highlights and analyzes the impact of the system on the 
company, by comparing the quality objectives before and after implementation, and 
13 
  
attempts to contrast the results with the literature review findings. In chapter 9 and 10, a 
final overview is given scanning the company’s profile, tracking possible limitations of 
the study, while future projection of the topic is attempted.  
2 Defining Quality in a laboratory – Description and 
purpose of ISO15189 
2.1 Quality Control and Quality Assurance  
Quality may be defined as an attribute of an individual or object. More often quality is 
defined as superiority of kind or as a level of excellence. Quality, however, has taken on 
more specific definitions that relate to manufacturing or industrial production3. Some 
have defined quality as ‘‘conformance to specifications’’, others have suggested that 
quality is meeting or exceeding customers’ expectations (Nakhleh RE, 2006). 
Assessment and implementation of quality control (QC) in a medical laboratory, 
especially in histopathology and cytopathology, is not easy as its output is wholly 
qualitative rather than quantitative (Adyanthaya S, Jose M, 2013).  QC checks in a 
histopathology lab will include accurate patient identification, specimen fixation, 
adequate processing, appropriate tissue embedding techniques, unacceptable artifacts and 
inspection of controls to determine correctness of special stains and highly advanced 
diagnostic methods (Bancroft JD, Gamble M, 2008). It is the responsibility of the 
pathologists to perform the final quality control examination as they read the slide and 
determine whether the slide is adequate for the diagnostic interpretation (Adyanthaya S, 
Jose M, 2013).  Participation in external quality assurance (EQA) programs also 
contributes valuable information for the quality level of a lab. Quality Assurance (QA) 
involves a system of review procedures conducted by personnel not directly involved in 
the laboratory process4. Statistical analysis of quality control provides the data for quality 
assurance activities where correlation of errors, complaints, failures or other unexpected 
results are evaluated against the laboratory expectations. Participation in external 
                                                 
3 Quality. From Wikipedia, the free encyclopedia, http://en.wikipedia.org/wiki/Quality. 
4 http://www.ipcc-nggip.iges.or.jp/public/gp/english/8_QA-QC.pdf.(Last accessed on September 2016) 
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programs also contributes valuable information for a quality assurance program 
(Adyanthaya S, Jose M, 2013).  
2.2 The purpose of ISO15189 
Accreditation according to an internationally recognized standard such as ISO15189 is 
increasingly acknowledged as the single most effective route to comprehensive laboratory 
quality assurance, and many countries are progressively moving towards compulsory 
accreditation of medical testing laboratories (Harper J.C., S. SenGupta, 2010). 
International Standard 15189 is based upon ISO/IEC17025 and ISO9001, and specifies 
requirements for competence and quality that are particular to medical laboratories 
(ISO15189:2012E, 2012). As it is stated in the introductive chapter ‘This International 
Standard is not intended to be used for the purposes of certification, however a medical 
laboratory’s fulfilment of the requirements of this International Standard means the 
laboratory meets both the technical competence requirements and the management system 
requirements that are necessary for it to consistently deliver technically valid results 
(Table 3). 
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Table 3 Definitions and comparison of accreditation, certification and licensing 
Term Definitions Involves Delivered by 
Accreditation Procedure by which an 
authoritative body gives formal 
recognition that a body or person 
is competent to carry out specific 
tasks 
Formal recognition by 
an independent body of 
technical competence, 
as well as compliance 
to a QMS 
The ‘authoritative body’ is 
the national accreditation 
body of the country 
concerned. A complete list 
for Europe is available at 
http://www.europeanaccre
ditation.org/content/ea/me
mbers.html 
Certification Procedure by which a third party 
gives written assurance that a 
product, process or service 
conforms to specific requirements 
Assurance of 
compliance to a QMS, 
most commonly ISO 
9001. The scope is 
variable but (in contrast 
to accreditation), there 
are no formal 
requirements for 
technical competence 
A country may have many 
‘third parties’ able to 
provide certification 
Licensing The permission, permit from a 
governmental agency to operate a 
laboratory 
Licensing of health-care 
facilities is distinct 
from accreditation and 
certification and does 
not necessarily require 
any evaluation of 
quality management or 
technical competence 
Usually mandatory and 
government-imposed 
 
The philosophy is to provide comprehensive cover of medical testing in the pre-analytical, 
analytical and post-analytical phases, including ‘arrangements for acquisition, patient 
preparation, patient identification, collection of samples, transportation, storage, 
processing and examination of clinical samples, together with subsequent validation, 
interpretation, reporting and advice, in addition to the considerations of safety and ethics 
in medical laboratory work’ (ISO 15189:2012E, 2012, J.C. Harper, S. SenGupta, 2010). 
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2.3 ISO 15189 requirements for competence 
ISO 15189 contains two main sections: management requirements and technical 
requirements, presented on Table 4. 
Table 4 Requirements of the ISO 15189 standard 
Management Requirements Technical Requirements 
Organization and quality 
management 
Personnel 
Quality management system Accommodation and environmental 
conditions 
Document control Laboratory equipment 
Review of agreements Pre-examination procedures 
Examination by referral 
laboratories 
Examination procedures 
External services and supplies Assuring quality of examination 
procedures 
Advisory services Post-examination procedures 
Resolution of complaints 
Identification of control of 
non-conformities 
Corrective action 
Preventative action 
Continual improvement 
Quality and technical records 
Internal audits 
Management review 
Reporting results 
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2.3.1 Managements Requirements 
2.3.1.1 Organization and Quality Management 
To achieve accreditation, a lab needs a quality manual, quality policy, with certain 
measures to ensure document control, record control, sample control, all of which form 
the QMS. A QMS is essential for the smooth running and maintenance of quality in a lab 
(Vendrell X, Carrero R, 2009). The laboratory under study has a designated quality 
manager responsible for maintaining the quality manual, implementing the quality policy 
and ensuring the application and development of the QMS.  
2.3.1.2 Document Control 
There are four types of documents that need to be written: 
o Policies: statements that the laboratory will follow particular courses of action. 
o Standard operating procedures (SOPs) that provide instructions on how to enact 
policies and how to perform the different activities of the lab.  
o Forms: are used to ensure traceability of all relevant actions and results including 
training logs, induction records, and personnel forms, outcomes of internal audits 
and minutes of meetings. 
o External documents: include laws, regulations, health and safety requirements, 
guidelines and manuals, as well as documents of other labs (ISO 15189:2012E, 
2012, J.C. Harper, S. SenGupta, 2010). 
2.3.1.3 Review of agreements 
The laboratory should have documented procedures for the establishment and review of 
agreements for providing medical laboratory services to third parties.  
2.3.1.4 Examination by referral laboratories 
A documented procedure is needed for selecting and evaluating referral laboratories and 
consultants who provide opinions as well as interpretation for complex testing in any 
discipline.  
2.3.1.5 External services and supplies 
The laboratory selects and approves suppliers based on their ability to supply external 
services, equipment, reagents and consumable supplies in accordance with its 
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requirements. A list of selected and approved suppliers of equipment, reagents and 
consumables is maintained. 
2.3.1.6 Advisory Services 
The laboratory offers guidelines and communication arrangements with users on advising 
on choice of examinations and use of the services. Specimen acceptance criteria are 
preferable to be uploaded on the laboratory’s website. 
2.3.1.7 Resolution of Complaints 
The completion of a questionnaire is regarded as a documented procedure for the 
management of complaints or other feedback received from clinicians, patients, laboratory 
staff or other parties. Records of complaints and their investigation and the corrective 
action taken, are maintained. 
2.3.1.8 Identification and control of non-conformities/ Corrective actions/ 
Preventative actions 
‘Non-conformity’ (also known as non-compliance) exists when any of the laboratory’s 
activity is identified as not conforming with its own procedures or to the agreed 
requirements of the requesting clinician or the QMS. The laboratory is required to react to 
the nonconformity by initially taking ‘corrective action’ to eliminate or reduce the effect 
of the non-conformity. In the case of ‘critical’ non-conformities, that may have an impact 
on patient care, the corrective action may need to be performed urgently (ISO 
15189:2012E, 2012, J.C. Harper, S. SenGupta, 2010). 
2.3.1.9 Continual improvement 
Through the use of management reviews a laboratory continually improves the 
effectiveness of the quality management system, by checking and evaluating quality 
indicators, including both technical and management aspects, to cover as much of the 
laboratory’s activity as possible. 
2.3.1.10 Internal Audits 
Internal audits review and evaluate laboratory activity and the QMS with respect to set 
criteria, to evaluate the extent to which services meet the needs and requirements of users 
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and comply with the accreditation standard (J.C. Harper, S. SenGupta, 2010). Internal 
audits are conducted by the lab’s Quality Manager every year. 
2.3.1.11 Management review 
The review aims on one hand to ensure the effectiveness of the services and the QMS for 
patient care, and on the other hand to identify and introduce any necessary changes and 
improvements. Some of the key points to review are the outcome of recent internal audits, 
the outcome of external quality assessment, feedback, including complaints and other 
relevant factors from clinicians, patients and other parties, non-conformities, and 
monitoring of TAT. 
2.3.2 Technical Requirements 
2.3.2.1 Personnel 
Laboratory management documents personnel qualifications that reflect the appropriate 
education, training, and experience needed. The administrative, management and 
laboratory staff is under continuous training programs for the use of newly acquired 
machinery and equipment and health and safety issues.  
2.3.2.2 Accommodation and environmental conditions 
The laboratory’s space should be designed to ensure the quality, safety and efficacy of the 
service provided to the users and the health and safety of laboratory personnel, patients 
and visitors. Protective measures and actions have been undertaken such as lighting, 
ventilation, noise, water, waste disposal etc. in accordance with published guidelines 
(Thornhill AR, de Die-Smulders CE, 2005). 
2.3.2.3 Laboratory equipment 
For the purposes of this International Standard, laboratory equipment includes hardware 
and software of instruments, measuring systems, and laboratory information systems, 
reagents, calibrators and quality control materials; consumables such as media, pipette 
tips, glass slides, etc. The laboratory maintains a documented procedure for the selection, 
purchasing and management of equipment. Complete equipment records are maintained 
and instructions for use are readily available to the relevant personnel. 
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2.3.2.4 Pre-examination procedures 
Guidelines for sample collection that includes information for users (clinics, doctors, 
technicians) and patients, test ordering and patient referral, specimen collection 
guidelines, recommended handling and processing, transportation, reception, and storage 
instructions, should be available. Rapid and frank communication with the referring 
clinician should be included in the procedure to attempt to resolve any problem and also 
to reduce the risk of recurrence (J.C. Harper, S. SenGupta, 2010). 
2.3.2.5 Examination (test) procedures 
All examination procedures used are validated, and those used without modification are 
subject to independent verification by the laboratory before being introduced into routine 
use5.  
2.3.2.6 Assuring quality of examination procedures 
The laboratory is supposed to design quality control procedures that verify the attainment 
of the intended quality of results (so called Internal Quality Control – IQC). For example, 
all pathological cytology specimens are cross-checked with the corresponding tissue 
biopsy specimens, in order to confirm and verify the accuracy of the diagnostic report. In 
addition, inter-laboratory comparisons take place three to four times every year, through 
participation in external quality assessment programs or proficiency testing programs. 
That way reproducibility, repeatability and verification of results are ensured. 
2.3.2.7 Post-examination processes and reporting of results 
The authorized personnel review the results of examinations before release to patients or 
clinicians, and evaluate them against internal quality control and, as appropriate, available 
clinical information and previous examination results. The laboratory shall have clearly 
documented procedures for releasing of examination results, including designated 
personnel responsible for releasing the results and to whom they can be released. 
                                                 
5 ISO 15189:2012, 5.5.1.2 
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2.4 Best Practices for the efficient rollout of the QMS 
implementation 
During any laboratory’s preparation period top management is responsible for planning, 
monitoring and supervising multiple aspects and different levels of the company, 
involving human, physical and financial resources. Not a few best practice documents are 
published in the literature in an effort to assist other laboratories that seek accreditation. 
Valentina Anisimova (Anisimova Valentina, Tjeerd A.M. Datema, 2015) highlights that 
one of the core best practices is securing funding through a pre-QMS assessment. Funding 
should also be sustainable for QMS maintenance.  
Active commitment from the start, applying leadership skills and providing direction 
through the whole process is a crucial practice that will result in staff engagement. 
Additionally, clear and constant internal and external communication channels are 
essential to exist. By this way all quality objectives are clearly communicated to the 
employees, while externally stakeholders are informed about the needs of the company, 
and customer requirements are identified. A full time, competent, qualified and dedicated 
Quality Officer (QO) is strongly suggested to be appointed. Especially at the start of the 
QMS implementation process management should ensure adequate training for key 
positions. This provides better competence and effective staff engagement.  
Laboratory management should anticipate initially increased workload, thus it should be 
continuously monitored so lab management can adequately react before workload 
becomes too high affecting negatively routine work. Another important practice is 
providing adequate equipment maintenance capacity, possibly by including a contract for 
preventive maintenance when purchasing new equipment, or by training one or more staff 
members to provide maintenance themselves. Regarding procurement processes, ideally a 
pre-QMS implementation assessment should be carried out, for a potential increase in 
demand for supplies may emerge. Finally, as a part of a pre-QMS implementation 
process, top management should assess if the facilities comply with biosafety and 
biosecurity requirements. If otherwise immediate improvement actions should be 
followed, as this could affect QMS assessment.  
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3 Factors that contribute to errors & errors reduction 
strategies 
3.1 Factors that contribute to errors 
With respect to error reduction in medical laboratory practice and specifically in 
pathology routine workflow, it is crucial to understand how errors occur. By this way 
error reduction strategies, that have been developed and tested in other areas of medicine, 
may be applied. Two of the most important factors are incorrect or improper patient 
identification and incorrect or incomplete clinical history. Complexity is regarded as 
another critical factor. The higher the steps in a process test cycle, the higher the chance 
of error occurrence. In a 25 steps process, if a step has a 1% chance of error, then the 
chance of error increases to 22%. With a 50 steps process, the chance of error is 39% 
(Spath PL, 2000). Cancer diagnosis should be based on the use of consistent diagnostic 
criteria. Any inconsistency may yield errors that will impact patient’s treatment (Schnitt 
SJ, Connolly JL, Tavassoli FA, 1992). Moreover, errors may occur if any malfunction 
appears to a machine, whereas humans are prone to errors because of distraction or 
boredom (Nakhleh RE, 2006). Finally at times of stress, such as increased workflow, or 
shortage of workers, there is an increased risk for errors occurrence.  
3.2 Statistical data of most frequent errors 
The majority of errors happen outside of the laboratory in the pre-analytical (46%-68%) 
and post-analytical stages (18%-47%) (Plebani M, 2009). During the analytical stage 
errors happen less frequently but still significantly, estimated to be between 7% and 12% 
(Plebani M, 2006, Karla J, 2004). In a study of medical malpractice cases against 
pathologists, Troxel noted that 4 of 218 claims were attributable to patient 
misidentifications at some point in the surgical pathology process (Troxel DB, 2000), and 
in a follow-up study, he noted a sharp increase in histology errors, with 13 of 272 claims 
attributable to specimen mix-ups and 2 of 272 to mislabeled slides (Troxel DB, Richard 
W. Brown, 2015). More recently, in a study of 227 root cause analyses in the Veterans 
Health Administration, Dunn and Moga identified 8 cases in which mislabeling of 
anatomic pathology specimens, slides, or tissue cassettes led to significant patient harm, 
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including unnecessary surgery (lung lobectomy, prostatectomy, hysterectomy), delays in 
diagnosis, and necessity for repeat procedures (Dunn EJ, Moga PJ, 2010, Brown W. 
Richard, 2015). The College of American Pathologists (CAP) reported a comprehensive 
study involving 136 institutions, where a labeling error rate of 1.1 per 1000 cases, with 
mislabeling rates of 1.0, 1.7, and 1.1 per 1000 for specimens, blocks, and slides, were 
reported respectively (Nakhleh RE et al) 
3.3 Error reduction strategies 
Routine tasks are a usual phenomenon in medical laboratories. Preparation and cleaning 
of the histology laboratory, preparation of gross rooms, daily maintenance of specialized 
equipment (tissue processors, microtomes and cryostats) are some of those worksheets 
that involve the technologists. The introduction of checklists, promoting automation, is a 
simple way to reduce errors, by reducing reliance to memory (Meier FA, Varney R, 
Bansal M, 2005). Improved information access is a vital parameter that reduces 
misdiagnoses rates, because in many cases, such as biopsies or frozen sections, 
interpretation of results depends on clinical data. 
The introduction of computers usage on a daily basis prevents from common mistakes 
that may happen during accessioning of surgical specimens or reporting of results 
(Branston LK, Greening S, Newcombe RG, 2002).  The use of standardized operating 
procedures and standardized diagnostics terminology protects technicians and doctors 
from making errors respectively, on one hand by eliminating confusion as to which 
procedure technicians should follow, and on the other hand by determining the correct 
treatment that is to be given to patients, through the use of standardized terminology 
(Petersen D. Human, 1996). Finally, multiple handoffs are a characteristic of the routine 
work in a pathology laboratory (collection, accessioning, grossing, staining, reporting, 
archiving). Each of these steps involves a potential of mishaps. Restrict labelling 
requirements, and the use of barcode technology safeguard the system regarding the 
pitfalls present at handoffs. The most significant reductions in specimen misidentification 
and labeling errors of blocks and slides have been achieved through the implementation of 
bar coding on all specimen containers, blocks, and slides (Abbuhl MF, Ferguson KL, 
2009, Zarbo RJ, 2009, Fabbretti G, 2011, D’Angelo R, Zarbo RJ, 2007). The Patient 
Safety Goals of the Joint Commission, the primary accrediting agency for hospitals in the 
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United States, call for the use of at least 2 patient identifiers on every specimen when 
providing laboratory services6.). 
4 ISO15189 implementation in laboratories across the 
world – a review of the literature and documented 
impact 
4.1 Current global trends 
The introduction of the latest third revision of ISO15189 in 2012, has given a new 
worldwide impulse to the use of this standard that has been particularly developed for 
medical laboratories (Marc H.M. Thelen, Florent J.L.A. et al). The growing global 
recognition of ISO15189 also appears from the fact that some governments make it 
mandatory for medical laboratories or else insurance organizations (either public or 
private) demand it for reimbursement (Marc H.M. Thelen, Florent J.L.A. 2015). In some 
countries more general standards, such as ISO90017 for quality systems or ISO17028, are 
still used. In the US, medical laboratories are accredited for moderate or high-complexity 
laboratory testing by approved organizations according to Clinical Laboratory 
Improvement Amendments (CLIA) rules9. 
 A systematic review of comparative quality of private and public ambulatory health care 
in low and middle income countries showed both public and private sectors scored low on 
infrastructure, clinical competence and practice, nevertheless private sector performed 
better with regard to responsiveness and effort, indicating that private sector is more client 
centered (Berendes S, et al, 2011).  In Canada, accreditation to ISO 15189-based 
standards is mandatory in two provinces. The Ontario Laboratory Accreditation (OLA), 
an IQMH-partner, has already accredited more than 200 labs to the standard in the 
province of Ontario (G. J. Flynn, J. Coffey, 2011). Using search engines including 
                                                 
6 Laboratory services: 2014 national patient safety goals. The Joint Commission Web site. 
http://www.jointcommission.org/standards_information/npsgs.aspx. (Accessed August, 2014) 
7 ISO9001-2008 Quality management systems – Requirements 
8 ISO/IEC 17025-2005, General requirements for the competence of testing and calibration laboratories for 
testing laboratories 
9 http://www.cms.gov/Regulations-and Guidance/Legislation/CLIA/Downloads/AOList.pdf 
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MEDLINE and Web of Science (search terms: medical laboratory AND quality 
management AND ISO 15189 AND accreditation, language filter: English, publication 
date: 2003-2016) led to the selection of 16 publications involving the introduction of that 
specific ISO standard in various types of laboratories all over the world.  
In a review of College of American Pathologists (CAP), Joint Commission International 
(JCI), South African National Accreditation Services (SANAS), United Kingdom 
Accreditation Services (UKAS), Clinical Pathology Accreditation (CPA), and National 
Association of Testing Authorities (NATA), online registers for accredited laboratories in 
sub-Saharan Africa, only 3 International Laboratory Accreditation Cooperation–affiliated 
national accrediting bodies and fewer than 30 laboratories outside of South Africa were 
found to having been formally accredited, primarily in the private sector (Trevor F. Peter, 
Philip D. Rotz, 2010), or parastatal or donor-supported research facilities (Gershy-Damet 
GM et al, 2010). 
4.2 European trends 
In Europe, accreditation is provided by the national accreditation body, which should be a 
member of EA (European cooperation for Accreditation). The detailed procedure varies 
slightly between accreditation bodies, but typically involves one or more external audits 
by a lead auditor from the accreditation body and a technical expert, specialized in the 
discipline (J.C. Harper, S. SenGupta, 2010). In France, for instance, all medical 
laboratories must be accredited by Comité français d’accréditation (Cofrac) by 2020, a 
process that started in 2010. In Belgium it is mandatory for certain disciplines (Marc H.M. 
Thelen, Florent J.L.A, 2015). The frequency of assessments and surveillance visits differs 
from country to country and ranges from 1 to 4 years.  
A survey was carried out in 2005 to explore the status of accreditation in EU countries. 
The questionnaire was sent to representatives of clinical biochemistry and laboratory 
medicine societies of EU countries. At the time of the survey Greece had not yet started 
the accreditation of medical laboratories ( 
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Table 5) (Wim Huisman, A. Rita Horvath, 2007). 
 
 
 
Table 5 Number of accredited laboratories  
                                                                                                                                          
Results are presented as number of laboratories (% of total). In Hungary it is possible to 
accredit medical laboratories according to ISO 17025 and/or 15189. At the time of the 
survey, however, all accredited laboratories used the ISO 17025 standard. In the UK, the 
laboratory service is accredited and it is possible to grant accreditation to the whole 
service or to part of it only. In the latter case, the laboratory is granted partial 
accreditation. Up to the date of our survey, most laboratories were accredited according to 
the old CPA standards fully or partially. However, laboratories had started to use the new 
ISO 15189-aligned CPA standards as well, and 101 laboratories were fully and 116 
laboratories partially accredited. Greece had not yet started accreditation. According to 
the information depicted on  
Accreditation LV NL NO PL SE SL SK UK 
ISO 15189  122 
(30%) 
+98 
applied 
 4  0    6 
(4%) 
  101 (9%) 
fully, 116 
partially 
ISO 17025    5 
(4%) 
 15  85%    
Accreditation AT BE CZ DE ES FI FR GR HR HU IE 
ISO 15189     22 
(10%) 
    3 
(0,3%) 
  3       
ISO 17025         ? 
(1%) 
  90 
(3%) 
    6 
(3%) 
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Table 5, in 20% of the countries EN/ISO 15189 is used exclusively. In The Netherlands, 
30% of all types of medical laboratories and 70% of clinical biochemistry laboratories 
are accredited to EN/ISO 15189. In Sweden, the rate of accredited laboratories is even 
higher at 85%, most of which are accredited to ISO/IEC 17025, but some also to EN/ISO 
15189. 
Table 6 indicates that in most countries surveillance is carried out annually. 
Table 6 Frequency of surveillance visit 
Frequency of 
surveillance 
visits 
AT BE CZ DE ES FI FR GR HR HU IE 
None     Y     Y    Y 
Every 1,5 
years 
 Y           
 
 
Every year     Y   Y    Y  
 
It is concluded that almost all countries have annual surveillance programs (Table 6), 
Poland and Hungary being an exception. 
Frequency of 
surveillance 
visits 
LV NL NO PL SE SL SK UK 
None       Y        Y 
Every 1,5 
years 
        
Every year   Y  Y  Y Y Y  
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4.3 Situation in Greece 
The Hellenic Accreditation System (ESYD) which was established by the Law 3066/2002 
with the purpose of the materialization, implementation and administration of the 
National Accreditation System, was transformed and incorporated as an autonomous 
Operational Accreditation Unit at the National Quality Infrastructure System (ESYP) 
established by the Law 4109/2013. For granting accreditation certificate, an on-site 
assessment is carried out of the candidate conformity assessment body by a team of 
assessors and possibly experts, whose members have in-depth knowledge of the relevant 
technical subject and experience in the assessment of quality management systems10. 
A detailed research revealed that there are 241 laboratories in Greece that provide any of 
the following services separately or jointly: histopathological services, cytopathological 
services, and molecular diagnostic services. In total 15 of them are currently accredited 
according to ISO15189:2012 standard. That corresponds to 6.22% of all laboratories. The 
laboratories that provide histopathological services exclusively are 55, where 3 of them 
(5.45%) are accredited. The corresponding proportion of exclusively cytopathology 
laboratories is 2.1%. 
4.4 The pros and cons of ISO15189 accreditation by 
experienced laboratories 
4.4.1 The pros 
Performance improvement as well as benefits to both laboratory customers and laboratory 
personnel seems to be strongly related to QMS implementation, according to some 
authors’ experience (Audu RA et al 2012, Berwouts S, Morris MA, Dequeker E, 2010). 
Furthermore, traceability, work satisfaction, reliability, reproducibility, transparency, 
uniformity and focus on critical points seem to be all improved through a QMS 
implementation program (Flegar-Mestric Z et al, 2010, Zeh CE et al, 2010). 
Implementation of technology is recorded to improved performance. Barcode 
identification systems almost halved ID band defect rates, and electronic order entry 
systems were associated with lower ID band defects. Monitoring of generic elements in 
                                                 
10 http://esyd.gr/portal/p/esyd/en/esyd.jsp  
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the testing process led to increased adequacy of critical value notification, reduced 
turnaround times and frequencies of corrected reports (Nakleh RE et al, 2014). 
Another study (Kumar SA et al, 2014) highlighted that analytical error rate showed the 
largest improvement; falling from 1.26 per 1000 to 0.72 per 1000 during the 2-year 
monitoring period. In a Q-Probes Study from 94 laboratories in USA that captured 
customer satisfaction in anatomic pathology, institutions with a specific TAT goal for 
surgical pathology resection specimens had significantly higher overall satisfaction 
scores, while institutions with a policy for alerting clinicians of medically critical values 
in surgical pathology had higher percentages of excellent/good ratings for notification of 
significant abnormal results. Inclusion of images in pathology reports had higher 
percentages of excellent/good ratings for tumor board presentations.  
A College of American Pathologists Q-Probes study of 5384 surgical biopsies showed 
that pathologists signed off 85.9% of 5384 biopsy diagnoses by the second working day. 
Another publication presented that the   median   TAT   for   all institutions was 2.72 
calendar  days,  with  a  wide  10th  to 90th   percentile   range   (6.23–1.22   days) 
(Volmar KE et al, 2015). 
4.4.2 The cons  
On the other hand other publications criticize QMS implementation as a time consuming 
process that increases workload (Berwouts S, Morris MA, Dequeker E, 2010, Guzel O, 
Guner EI, 2009). The most frequently mentioned requirement for successful QMS 
implementation is the engagement of staff with the process, which was also mentioned as 
one of the most difficult factors to deal with (Audu RA et al, 2012, Zeh CE et al, 2010). 
They indicate that staff has a natural reluctance to change (Figure 3) and that convincing 
them of the value of a QMS is pivotal to success (Anisimova V et al, 2015). 
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Figure 3 Stages which people go through in times of change and the influence on performance over 
time. Based on the Kübler-Ross model as presented by Berwouts et al, 2010. Taken from “ISO 15189 
Quality Management System Implementation: Look Before You leap. Best Practice Guidance 
Document. © TB CARE I 2015” 
 
Most laboratory employees view data collection  for  quality  indicators  as  extra  work  
that  hinders their  ability  to  do  their  ‘‘real’’  jobs (Zarbo RJ et al, 2003).  As a result, 
there is reluctance to collect and report data and for management to be actively engaged in 
reviewing and taking necessary actions. As far as critical values notification, Sharif  et al  
found  absolutely  no  clinical  details  in  34%  of  their  cases (Sharif MA et al, 2007). 
On the contrary in  similar  focused  studies,  Burton et al., found a lower incidence of 
inadequate clinical details in their study with 2.4% and 6.1% respectively [Burton JL, 
Stephenson TJ, 2001). Kumar et al showed that increased TAT was a common recorded 
non conformity issue (4.62/1000). 
5 Company profile and QC characteristics 
5.1 Short history and process flow  
5.1.1 Short history 
Microdiagnostics Ltd is a medical laboratory that operates in the private sector offering 
histopathology, cytopathology and molecular diagnostics services. Based in Thessaloniki, 
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it is considered one of the main pathology providers in Northern Greece, covering 
systematically a large geographical area, mainly east, central and western Macedonia. 
Established in 1979, it was continuously adapting to its client needs, by investing on 
physical and human resources. Upgrading its technical equipment, customizing digital 
operating and information software, and introducing specialized diagnostic techniques is 
still a way for the company to support the core value of the laboratory: diagnostic quality 
and accuracy. From as many as 3 employees, the laboratory grew over the years and 
currently it consists of 17 individuals, 6 pathologists, and administrative personnel with 4 
people, 6 histotechnologists, and one generalist. 
5.1.2 Process flow 
As a histo-cytopathology laboratory the type of specimen to be submitted and analyzed is 
either human tissue, or body fluids. In Figure 5 the process flow of a specimen is 
depicted. During the pre-analytic phase, the collected sample is placed securely in a 
container, prefilled with a fixative (usually formaldehyde). The clinician’s assistant is 
preparing a medical referral, filling all important clinical information and patient’s 
medical history. The pair container-referral is transported to the laboratory, where it is 
accessioned. From now on the “pair” is given a unique protocol number with which it is 
recognized through all the process flow in the lab. The analytic phase begins with the 
technical macro-analysis of the specimen. Initially, the histopathologist macro-dissects the 
tissue sample in the grossing room, distinguishing the parts that are to be analyzed 
microscopically. These tissue-parts are placed into cassettes (Figure 4), loaded on a tissue 
processor for several hours, and then embedded on a specific embedding station to 
produce the paraffin block, in which the sample is embedded (Formalin Fixed Paraffin 
Embedded tissue – FFPE). 
By cutting the FFPE on a microtome a thin slice is obtained, placed on a slide and then 
stained manually or automatically. The stained slide is given to the pathologist. 
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Figure 4. A tissue cassette (dark yellow), two paraffin blocks (FFPE), one container, and slides (one 
with a tissue section adhered on it) 
 
FFPE preparation may last from 24 to 72 hrs, depending on the type of specimen (small, 
large) and the fixation needs. The pathologist interpreting the slides may need a few 
minutes to several days, in order to conclude to a definitive diagnosis, depending on the 
nature of the disease and the necessity to perform advanced diagnostic techniques. The 
post-analytic phase involves the dictation of diagnosis by the pathologist, followed by 
transcription of the report performed by a secretary, verification of the report by the 
pathologist and finally delivery of the report to final recipient (clinician and/or patient). 
33 
  
Figure 5. Process flow of a specimen, from ablation to receipt 
 
5.2 QC characteristics of Microdiagnostics Ltd before 
ISO15189 implementation 
Regarding human resources, a formal organizational chart depicting each individual’s 
position, scope and field of responsibility was missing. Although all personnel was 
working and interacting with each other with no significant problems, no formal job 
descriptions were available. No immune records were held, nor were HR records 
archived. Performance appraisals are still not conducted. The overall cultural trend was 
that of solidarity and complementarity, but when it came to accountability issues things 
were becoming complicated. At the top management level no management reviews were 
taking place, nor were internal audits held systematically. Since almost the beginning of 
the company, customized PC software was in use, for archiving of patients’ tests, and 
clinicians’ ID information. No ERP/CRM was installed, thus making any statistical 
information difficult to obtain. Inventory was not recorded and supply order forms were 
not kept officially. All supply orders were given orally, not in a written format.   
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Accession of specimen received was done manually. Whether clinical information was 
written on the referral or not, it was not officially monitored and controlled. Labelling of 
blocks and slides was performed manually. Internal or external Quality Control (IQC, 
EQC) schemes were not performed, thus no reproducibility, repeatability and verification 
indicators were checked. Table 7 presents the operational characteristics of the company, 
with respect to the three testing phases. One can conclude that the laboratory was facing 
great difficulty in monitoring and controlling Quality. 
6 Methodology 
The laboratory applied for accreditation to the Hellenic Accreditation System (ESYD), by 
submitting the required documentation on May 2016. The overall preparation of the 
laboratory for the QMS implementation and final assessment was orchestrated by a 
private advisory company “Business Analysis”, which was initiated and progressively 
evolving from January 2016. A detailed cost analysis is given, regarding all related 
expenses to ISO15189 requirements.  
Table 7. Operational characteristics of the company with respect to QC before ISO15189 implementation 
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To estimate the impact of QMS on the overall laboratory’s performance, a process 
mapping had to be initially developed for a better understanding of the key drivers. The 
main QMS evaluation method was the fulfillment of questionnaires by the employees, 
who were considered the right ones to have insight about the factors and conditions that 
facilitated the efficient QMS implementation, and the challenges encountered during the 
accreditation process, since all of them were engaged in the process. More specifically, 
obtaining feedback from employees through questionnaires, was perceived to be the safest 
method, since no LIS was installed in the past, making access to quantitative data real 
difficult. All data produced by the questionnaires were analyzed and depicted as bar charts 
using Microsoft Excel. To obtain insights regarding employees’ perspective of ISO15189 
and their overall experience, they were asked to fulfill a second questionnaire with the 
same format (APPENDICES 
 APPENDIX A 1 & APPENDIX A 2).  
Special attention was given to TAT estimation regarding small and large specimens, since 
this is a sensitive measure of any laboratory’s performance, judged by most of the 
clinicians. To evaluate customers’ satisfaction, clinicians in this case, a statistical analysis 
of questionnaires results was attempted and presented as percentages. All other key 
performance objectives were expressed as percentages, except for TAT which was 
expressed in days. A summarized table is displayed comparing the key objectives before 
and after QMS implementation. 
7 Preparations before final assessment 
7.1 Pre-assessment preparations 
For weaknesses to be detected (Chapter 5.2), a review of all procedures and processes was 
needed for both Quality Consultant, company’s manager and engaged personnel (from 
now on “the team”), to set time frames and deliverables. Short duration kick-off meetings 
for staff guidance and consultation were held frequently. After pre-analytical, analytical 
and post-analytical phases of testing were assessed, a quality manual was developed, 
which included standard operating procedures (SOPs) and laboratory policies for all main 
work processes. Many of them were posted on dashboards in an effort to be routinely 
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available as checklists. Staff was trained as internal auditors and with the contribution of 
Quality Consultant, internal audits were frequently held for evaluating QMS preparation 
progress. All working instructions –written on informal sheets till then- were written 
down formally, many of which posted on dashboards, and official written documents 
were printed, including more than 90 instructions and norms. All personnel was required 
to read and comprehend all working instructions. 
At the same time the digital existence of the company was being progressively formed 
and installed. The basic platform was a dedicated ERP/CRM software, purchased from a 
well-known Greek Company named “Entersoft”. That needed full customization for the 
specific needs of the laboratory that was taking place alongside the everyday routine 
work. It took more than 6 months for the software to reach a satisfying level of usage, and 
still (almost a year on) it is under continuous development. Responsible for this project 
was an IT private company, named “Neda Intelligent”. Contemporary, management 
appointed “MONKS”, an Integrated Communications Agency, to re-establish its website 
and control and manage the lab’s digital existence in general, including the social media.  
7.2 Pre-assessment evaluation and corrective actions 
A pre-evaluation assessment by ESYD was arranged on July 2016. All newly written 
documents, working instructions, supportive documents prepared with the Quality 
Consultant were sent to ESYD. The pre-assessment procedure lasted almost the whole 
day and arose 16 non-conformities, from which 2 were considered “important” and the 
rest “secondary”. On Table 8 all non-conformities and corrective actions are presented. 
  
Table 8 Pre-assessment non-conformities and subsequent corrective actions. Important non-
conformities are highlighted with red 
Non-conformity Corrective Action 
 No Contingency plan (CP) 
 No specified Top Management 
competences 
 A contingency plan was formed and 
added on Risk Analysis (RA) part 
 Top management competences were 
revised & Lab Manager was announced 
as responsible CP & RA 
 No acceptance criteria exist  A working instruction was added 
regarding specimen acceptance criteria 
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Non-conformity Corrective Action 
 No List of Contracts and Contracts 
review documentation 
 All available contracts listed on a main 
catalogue 
 Systematic and formal review of 
contracts was added in the master list 
 No referral lab evaluation 
 No subcontractor evaluation 
 Referral lab evaluation accomplished 
 Subcontractor evaluation accomplished 
 Methodology of tests and ISO 
certifications were examined. No Non-
conformities were found 
 No records of laboratory departmental 
meetings 
 A formal document was created and 
each meeting was recorded on it 
 No scheduled Internal audits  A formal schedule was created 
 No verification of Quality Consultant 
for internal audits (IA) 
 In Internal Audits Procedure a paragraph 
was added underlying the assignment of 
IA to an external partner 
 No Risk Assessment  Definition of Risk Assessment schedule 
and inclusion in the FMEA11 
 No Management Review for current 
year 
 Management review was carried out 
 No previous QMS training of personnel  ISO15189 presentation to personnel & 
training 
 No contingency plan training  Contingency plan presentation & 
training 
 No written procedure for equipment 
acceptance 
 Addition to equipment maintenance and 
identification 
 No acceptance criteria testing for 
antibodies purchased 
 New work directive for acceptance 
testing procedure 
 No verification testing of results (IQC12)  Verification testing in all results of the 
last 3 months & statistical analysis 
 No pagination of reports  Accomplished by updating the software 
 No posted schedule regarding 
EQC13schemes 
 Four year schedule for participation in 
EQC schemes 
 
                                                 
11 FAILURE MODE EFFECTS ANALYSIS 
12 Internal Quality Control 
13 External Quality Control 
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8 Final assessment 
8.1 Non-conformities and corrective actions 
Final assessment was scheduled for 8th of October 2016, leaving a period of almost two 
months for the laboratory to prepare and take the aforementioned corrective actions. A 
total of 10 secondary non-conformities were given to Top Management, meaning that 
without any serious non-conformity, the laboratory succeeded in accrediting its scope of 
interest. 
Table 9 Main Audit non-conformities and corresponding corrective actions taken 
Non-conformities Corrective action 
 No assigned Deputy Quality 
Manager 
 A formal document was added in 
HR records 
 No formal authorization of 
pathologists to sign reports 
 A related document was added to 
HR records, signed by those 
concerned and by Lab administrator 
 No formal document for selecting 
& evaluating Suppliers and Referral 
Labs 
 Added in work directives 
 No schedule for IQC audits  A schedule was planned and posted 
on dashboard 
 No written confirmation that all 
personnel is aware of all Directives 
 All personnel signed the 
corresponding documented, each of 
which was added to HR records 
 Procedure of non-conformities 
insertion to the system is 
considered to be immature 
 Improvement of non-conformities 
insertion into the system, by 
including all necessary information 
 Number of non-accepted specimens 
& of accessioning errors should be 
monitored & recorded 
 Quality objectives as indicated were 
included in Management Review 
 Pap smear slides that are Negative 
after testing are not archived 
 New Directive, all slides 
independently are archived – 
Different archive for cytology ≠ 
histopathology slides 
39 
  
Non-conformities Corrective action 
 Accession number is not clearly 
visible on pap smear slides 
(uncoated slides) 
 Specific labels purchased for slides 
 Label printer installed 
 Barcode scanner installed 
 No statistical analysis of EQC 
results 
 Statistical analysis of EQC results 
 
ESYD required all non-conformities to be corrected, as a prerequisite for accreditation. 
Personnel faced no difficulty in taking corrective actions apart from solving the Pap smear 
slide archive matter and introducing new equipment for labelling Pap smear slides (Table 
9). Especially the first one required a redesign of its storage facilities, including the need 
for new storage cabinets. 
8.2 Cost of implementation 
As mentioned previously the decision to prepare and implement a QMS that provides 
accreditation for specific medical services involves an expenditure that is not 
inconsiderable. ESYD required a total of 4,503.65€ including pre-assessment and 
assessment evaluation costs. The consultant agency Business Analysis charged 2,480€ for 
the whole process. Competitors in the market charge a lot higher, around 5000€, so it can 
be considered a very good deal. According to the owners of the company the agency 
offers professional service and excellent communication through the whole process. One 
could stop here, but the author considered to include expenses regarding the purchase, 
development and customization of a laboratory information system. This is supported by 
the fact that essential elements of quality, such as traceability of specimen through all 
steps of the testing cycle, mismatch errors control, and transcription and verification 
errors avoidance, are all offered by a more advanced software, combined with barcode 
technology. Table 10 presents the total implementation expenditure. 
Table 10 Cost of ISO15189 implementation, including LIS development 
Companies Amount in Euros 
NEDA Intelligent 23,246.65€ 
ESYD 4,503.65€ 
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Business analysis 2,480€ 
Total 30,230.3€ 
There were many more expenses that the top management team decided to invest in, that 
were not included in the total. Equipment for automation of slide staining and slide 
covering, and cassette and slide printers (total cost around 55,000€) usage, contribute to 
standardization of procedures, saving time for the histotechnologist to deal with other 
aspects of the flow process, cutting input costs, but are not considered essentially 
prerequisites for successful ISO15189 system implementation. The expense for 
establishing and developing from scratch the digital aspect of the laboratory is dealt in the 
same manner. Total strategic marketing budget was around 20,000€. 
9 Results & Discussion 
9.1 Analyzing QMS Implementation impact – comparison with 
literature findings 
It is obvious that the whole process of gaining accreditation left a remarkable impact on 
Microdiagnostics Ltd. One could argue that this experience sort of transformed radically 
all aspects of the company. To begin with, top management pledged to introduce, prepare, 
implement and sustain each and every scope of tests that will be accredited, something 
that involves systematic funding. For the first time all procedures were written down in 
formal directives, given to all departments for review. Aspects of strategic human 
resources management were beginning to evolve. Apart from reviewing all contracts, each 
individual’s file was checked, contracts were revised were necessary, and employees were 
asked to verify that are aware of all working directives and norms, by signing appropriate 
forms. A training and developmental culture was introduced, in an effort to enhance 
employees’ loyalty and motivation. At least once a month top management holds 
meetings with all pathologists, to discuss routine matters, analyze trends and outer 
environment, engaging them to decision-making and problem solving. At the time of 
writing these lines, management funded secretarial training courses to administrative 
personnel. Additionally, participation in seminars concerning technical aspects, addressed 
to technologists is under serious consideration. All major improvements are depicted on 
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Table 13 Comparison of qualitative characteristics before & after ISO15189 
implementation in Microdiagnostics Ltd 
Impact in testing phase 1: A completely new website was developed, which hosted all 
relevant instructions addressed to clinicians and patients, for better specimen handling and 
transporting. Expensive and highly advanced equipment was installed, in an effort to 
eliminate mismatch errors. This was achieved by cassette and slide printers, that 
introduced an automated way for accessioning, and slide and block labelling. With the 
additional use of barcode technology the company set high standards with regard to 
misidentification errors minimization, and traceability capabilities. All these features were 
linked and integrated through a dedicated laboratory information system (LIS), developed 
and fully customized for the needs of the laboratory. 
As shown in Figure 6, neither of the individuals stated against improvement of all quality 
objectives in the post-analytic phase. Identification, accessioning and delivery errors seem 
to be substantially reduced. Note of worthy is that 30% of personnel states that “access to 
clinical history” has not been influenced significantly. In a closer look, one can realize 
that if the answers of the technical personnel are isolated (Figure 7), this specific objective 
improves (0% neutral). That reflects the fact that laboratorians, as the ones receiving the 
specimen, are responsible to request any additional clinical information, either form 
patients, or directly form clinicians, in case that the referral is not appropriately filled. 
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Figure 6 Statistics of quality objectives in pre-analytic phase. Results reflect answers collectively from 
all departments 
 
Figure 7 Statistics of quality objectives in pre-analytic phase. Results reflect answers of technologists 
alone 
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Impact in testing phase 2: As mentioned above, dedicated printers and barcode 
technology are intended to protect from labelling errors. To monitor quality with respect 
to scientific interpretation of tests, the laboratory enrolled in external quality control 
schemes, hosted by LABQUALITY and UKNEQAS in an effort to accredit Pap smear 
examination (current scope under study), non-gynecological cytology examination, 
immunohistochemical14 stains, and histological technical processes. This is an effective 
and recognized way of benchmarking, since hundreds of laboratories take part in these 
schemes, having the chance to compare their results with those of referral laboratories. In 
order to gain insights of reproducibility, repeatability and verification performance, the 
lab enacted in periodical internal control schemes. At the end of each month a certain 
percentage of positive results, border-line results, and negative results is taken out of 
storage, re-interpreted by the same pathologist (repeatability), cross-checked by another 
pathologist (reproducibility) in the same laboratory, and checked by a third one, not 
belonging to the lab’s team (verification). Again the majority of the participants expressed 
a significantly positive impact on most of the objectives, with labelling errors improving 
the most, as depicted on Figure 8. Eight percent of employees believe that EQC schemes 
do not improve diagnostic accuracy, contradicting all of the pathologists’ statements (see 
APPENDIX A 3). Both administrative and technical personnel seemed not to have fully 
understood the reason and the purpose of an EQC scheme. Further training and better 
interdepartmental alignment is proposed. 
                                                 
14 What is Immunohistochemistry (IHC)? 
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Figure 8 Quality objective collective statistics of analytical phase 
 
Impact on testing phase 3: Consistently, no negative impact was documented for all 
post-analytical objectives. Again, there was a variety with respect to “neutral” impact, 
while none of the pathologists seemed to share the same opinion (Figure 9 and Figure 10). 
Pathologists are closely engaged to errors in the last phase of the testing cycle, being able 
to better reflect real conditions. Figure 11 explains why “neutral” appears in post-
analytical phase. It was due to laboratorians’ unawareness.  
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Figure 9 Collective Quality objective scores in post-analytical phase. A significant percent has a 
“neutral” check. 
 
Figure 10 Pathologists’ Quality Objective scores in post-analytical phase. All of them reflect a positive 
impact of QMS in error avoidance, with no “neutral” check. 
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Figure 11 Technologists stated “neutral” impact of QMS with respect to all objectives, reflecting their 
unawareness in post-analytical matters 
 
Impact on Customer satisfaction and TAT: One major contribution of the LIS was its 
CRM module, which enabled both pathologists and administrative personnel to 
communicate with the outer environment, keep in touch with patients, monitor their 
needs, and essentially interact with physicians. Introducing a systematic use and statistical 
analysis of questionnaire surveys, filled in by both patients and physicians reflected the 
laboratories performance on its customers, gaining insight in their perception of the 
laboratory as a whole. Laboratory’s overall performance can be regarded as 
overwhelmingly successful, since the vast majority of physicians claimed to be “Very 
Satisfied” with the laboratory, in terms of TAT, communication with all departments, and 
response to requests (Table 12). 
Time of report deliverance presents great interest. Before QMS, 63% of gastric biopsy 
reports were delivered in 24 hrs, while after QMS 57% of reports was delivered in the 
first day after submission. This slight decrease should be attributed to the fact that during 
the second time frame the laboratory’s workload was substantially increased, since new 
equipment, new information software, and new directives were simultaneously 
introduced. TAT score for gastrectomies remained almost the same for both periods 
(62.5% and 66% respectively). Detailed information is presented on Table 11. 
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Table 11 TAT measured in days for gastric biopsies & large specimens of resected stomachs 
 
Table 12 Statistical analysis of Survey addressed to clinicians 
 
48 
  
 
9.2 The experience of the QMS implementation from 
employee’s perspective 
Especially at the beginning, employees were reluctant to change. During kick-off 
meetings there was tension and emotional strain was obvious. As top management 
confessed, frustration and denial (Figure 3) was some of the attributes that characterized 
both the technical and administrative personnel and less the scientific team. One of the 
main factors that contributed to general anxiety and tension was the development of a 
complete customized LIS, based on the ERP/CRM software. On one hand, the 
administrative personnel had to cope with the already installed simple software, 
participate in customization of the new software, and handle others’ requests. On the other 
hand, technologists had the challenge to get used in operating new automated machinery, 
Table 13 Comparison of qualitative characteristics before & after ISO15189 implementation in 
Microdiagnostics Ltd 
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and substitute most part of their manual procedures with digitalized ones. The increased 
workload influenced partially pathologists since there were times that ready-for-
interpretation-stained slides took more than usual to be prepared. 77% of all employees 
agreed that QMS implementation was difficult and all of them (100%) that workload had 
significantly been increased. 85% agreed that LIS increased workload, and that there was 
room for improving the work atmosphere. This negative effect mirrors the results of 
several earlier studies (Audu RA et al, 2012, Zeh CE et al, 2010), in that at the beginning 
employees are not only reluctant to change, but appear to fall into depression for a short 
time period. Worth of mentioning is that at the same time 100% of participants recognized 
the tremendous contribution of LIS in analytical and post-analytical errors reduction rate, 
a finding that is consistent with literature findings (Nakhleh RE, 2008). 
An important issue that top management is supposed to deal with is employees’ 
perception of quality and the close relation that ISO15189 has in establishing a continuous 
quality improvement culture. Statement 8 (Figure 12) highlights that 40% of them does 
not believe that implementation of ISO15189 contributed to performance improvement, 
30% is neutral, and 30% positively correlates performance improvement with QMS. At a 
closer look, 100% of pathologists agree that ISO15189 improves performance. Half of 
technologists stated that QMS does not improve performance, and the other half remained 
neutral. With regard to administrative personnel, 60% preferred to undervalue QMS’s 
contribution to performance, and 40% remained neutral. Therefore it can be claimed that 
heavy workload overshadows most positive aspects of ISO15189, especially the non-
medical personnel. What remains to be checked is employees’ perspective of ISO15189 
one or two years from present.  
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10 Overview 
Healthcare as a service-oriented profession, promotes Quality as a critical measure of 
excellence. Modern medical interventions rely heavily on laboratory testing; (Anisimova 
V, et al, 2015, Nakleh RE, 2006) hence, the quality of these services may affect patient 
safety and the effectiveness of treatments in an immediate way. Nowadays more than 
ever, Quality Assurance becomes especially critical in individualized cancer treatment, 
since healthcare professionals often order a batch of tests to assess the status of the 
patient’s disease before choosing a therapeutic plan. Under these circumstances, 
consistent laboratory results become a necessity. This can be achieved by setting 
standardized operating procedures (SOPs), framed by a quality management system 
especially addressed to medical laboratories.  
Figure 12 Aggregated rates of all participants in the questionnaire 
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To conclude, there are some key drivers that involve the whole ISO15189 implementation 
process, that emerged from the laboratory’s experience, most of which were noticed also 
in the literature review: 
1. Top management should be prepared to ensure a substantial number of funds for 
preparation procedures, pre-assessment evaluation, main assessment evaluation, 
annual fees for maintenance of accreditation, and for participation in external 
quality control schemes (Anisimova V, et al, 2015). 
2. Top management should closely be engaged through all the steps of ISO15189 
implementation, supervising progress of the system, monitoring and allocating 
human resources with respect to skills and capabilities, and 
3. Expect to deal with resistance to change, because a radical cultural re-
establishment is essential for a successful outcome (Nakleh RE, 2006, Anisimova 
V, et al, 2015). In harmony with literature findings, personnel did finally engage to 
comply with new SOPs (Audu RA et al, 2012). 
4. Constant training is needed to make the experience more convenient, accelerate 
processes, and help to get staff on board (Anisimova V, et al, 2015). 
5. Unaccredited laboratories often find impossible to obtain baseline performance 
data from the year’s prior accreditation. The same applies to the objectives used in 
this evaluation project (Gershy-Damet GM, et al, 2010). 
The fact that proper collection of data from the years before accreditation was not possible 
while this could be done for the years after ISO15189 implementation is a sign of the 
effect the system has, especially in terms of optimizing accessibility and availability of 
laboratory data. This in turn provides to the lab manager the opportunity to obtain 
important statistical data concerning various aspects of the company, and to take 
analogous actions. 
Microdiagnostics Ltd has the will not only to maintain the system, but through that to 
constantly improve its overall quality, by offering a trustworthy medical service, as quick 
as possible, without compromising its value. In the years to come Top management is 
bonded to manage things in that way, to combine QMS’s attributes with the newly 
introduced digital technology in the fields of pathology. Implementation of ISO15189 
should be dealt as a big opportunity to introduce Quality aspects in all operational and 
managerial levels of a medical company, offering better control, customer satisfaction, 
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and furthermore the capacity to widen the company’s business scope, by contracting or 
subcontracting with other private or public bodies.  
11 Limitations 
Pre-analytical phase is quite an extensive part in histopathology processing.  Hence, 
analysis of clinician requisition forms and collection errors could not be included in this 
study. Additionally, access to quantitative data was not possible since there was not any 
sophisticated software installed prior to QMS preparation period. Another potential 
limitation might be the fact that the study focused on a specific private medical 
laboratory, indicating that its documented facts and experience might not involve other 
areas of the country, or public sector. Nevertheless, a review of the literature yielded 
similar results to those that were mentioned in the present study; therefore, it can be 
supported that the findings can to some extent be safely extrapolated to laboratories with 
similar characteristics and conditions. 
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13 APPENDICES 
13.1 APPENDIX A 1 
EMPLOYEES’ EXPERIENCE & PERSPECTIVE of ISO15189 implementation 
Statement 
Strongly 
disagree 
Somewhat 
disagree 
Neither 
agree 
nor 
disagree 
Somewhat 
agree 
Strongly 
agree 
1.  The implementation of the QMS was 
difficult 
1 2 3 4 5 
2.  Quality of the facilities has changed 
over the past few years 
1 2 3 4 5 
3.  Safety in the laboratory has not 
improved over the past few years 
1 2 3 4 5 
4. Workload has increased significantly  
over the past few years 
1 2 3 4 5 
5.  I have more opportunities to participate 
in trainings/courses now, than before 
1 2 3 4 5 
6. Quality of equipment has been 
deteriorated over the years  
1 2 3 4 5 
7.  The work atmosphere at the laboratory 
could be far better 
1 2 3 4 5 
8.  Without ISO15189 the laboratory 
performance would be the same 
1 2 3 4 5 
9. Introduction of the LIS in routine 
increased workload 
1 2 3 4 5 
10. The use of LIS decreases errors 
(misidentification, labeling, transcription 
etc.) 
1 2 3 4 5 
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Please specify your department in the company (i.e. L for Laboratory, AD for administration and MD for 
Medical Doctor): ___________________________________
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13.2 APPENDIX A 2 
ISO15189 impact on MICRODIAGNOSTICS LtD Survey questionnaire   – QUALITY 
OBJECTIVES 
To help us provide benefits that meet your needs, please complete this survey and return it to Human 
Resources by November 12, 2016. 
Statement 
Strongly 
Agree 
Agree Neutral Disagree 
Strongly 
Disagree 
Define measure 
taken 
Pre-analytic phase 
Specimen delivery errors are 
significantly reduced 
      
Specimen identification errors are 
significantly reduced 
      
Accessioning errors are 
significantly reduced 
      
Access to clinical history is 
improved 
      
Analytic phase 
Block labelling errors are 
significantly reduced 
      
Slide labelling errors are 
significantly reduced 
      
Frequency of equipment defects is 
significantly reduced 
      
External quality control schemes 
(benchmarking) improve diagnostic 
accuracy 
      
Internal quality control schemes 
(reproducibility, repeatability, 
verification) improve diagnostic 
accuracy 
      
Post-analytic phase 
Transcription errors are 
significantly reduced 
      
Verification errors are significantly 
reduced 
      
Report delivery errors       
Incomplete reports       
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Please specify your department in the company (i.e. L for Laboratory, AD for administration and MD for Medical Doctor): 
_____________________________________ 
 
13.3 APPENDIX A 3 
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Additional Comments: 
